Hosted by the American Conference Institute, the 19th Annual FCPA & Anti-Corruption Conference for the Life Sciences Industry returns for another exciting year with carefully researched programming based on critical findings from the 2023 enforcement environment, along with insightful conversations with life sciences decision makers.

Recognized as the premier event for legal and compliance professionals, the 2024 event is projected to gather an unprecedented level of attention, attracting leaders from the top CRO, medical device, pharmaceutical, and biotechnology companies who are looking for new opportunities to connect and expand their professional horizons.

This year’s conference co-chairs include Claudius O. Sokenu (Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary, Avantor), and Natasha Trifun (Executive Director, Head of Compliance, R&D, Global Medical, External Funding and Global Functions, Alexion Pharmaceuticals). The 2024 co-chairs and speakers are honored to lead attendees through various in-depth sessions, including those analyzing DOJ/OIG compliance update best practices, compensation claw backs in the life sciences context, cross-border data privacy management, and more.The conference will feature updated session formats, interactive debates, revamped workshops and even more networking opportunities.

The Conference on FCPA & Anti-Corruption for the Life Sciences Industry takes place on May 9 – 10, 2024 at the New York City Bar Association, New York, NY.